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Background
Many studies on the genetic background of common
neoplastic diseases indicate that they may be the result
of hereditary mutations in cancer susceptibility genes,
such as BRCA1, CHEK2, CDKN2A, NOD2, NBS1.T h e
cancer occurrence in genetically predisposed mutation
carriers may be a matter of life expectancy, efficiency of
the immunological system, and cumulative action of
toxic environmental agents. Most cytostatic drugs used
in the treatment of cancers in oncological wards have
mutagenic and carcinogenic activity. The exposure to
them is difficult to avoid by the medical staff in their
daily work during preparation and administration of
drugs as well as during the contact with patients (physi-
cal examination, nursing care).
Aim
Investigations of nine Polish founder mutations: BRCA1
(5382insC, 300T/G, 4153delA), CHEK2(1100delC,
I157T, IVS2+1G®A), CDKN2A(A148T), NOD2
(3020insC) and NBS1(657del5) in healthcare personnel
of oncohematological ward, with respect to the age of
cancer diagnosis, a cancer family history and a number
of work years in contact with cytostatics.
Tested persons
75 persons (55 nurses, 16 physicans and 4 laboratory
workers) exposed to cytostatic drugs in their daily work.
In 10 of them during the period of employment in the
oncohematological ward a cancer was diagnosed: in 6
women breast cancer (BrCa), in 2 persons melanoma, in
one person secondary MDS-related AML, and in one
non-Hodgkin lymphoma (NHL). The mean number of
work years in contact with cytostatics, till the time of
molecular studies for the whole analyzed group, was
13.1 years (range 1-29 years) and for 10 people with
cancer diagnosis 15.2 years (range 7-27 years).
Methods
Mutations in BRCA1 (5382insC, 300T/G, 4153delA),
CHEK2 (1100delC, I157T, IVS2+1G®A), CDKN2A
(A148T), NOD2 (3020insC) and NBS1 (657del5) were
detected in DNA from peripheral blood by RFLP-PCR
and ASO-PCR techniques.
Results
A constitutional mutation was found in 24% persons:
NOD2(3020insC) in 10.7%, CDKN2A(A148T) in 6.7%,
CHEK2(I157T) in 5.3%, and CHEK2(IVS2+1G®A) in
1.3%. The frequency of NOD2(3020insC), CDKN2A
(A148T), CHEK2(I157T) and CHEK2(IVS2 1®G) was
significantly higher than in general Polish population
(10.7% vs. 7.3%; 6.7% vs. 3.5%; 5.3% vs. 4.8% and 1.3%
vs. 0.48%, respectively). Among 10 persons with cancer
in 6 (60%) a mutation was revealed: in 5 out of 6
women with BrCa and in one man out of two persons
with melanoma. In the group of women with BrCa a
50%, 16.7% and 16.7% frequency of NOD2(3020insC),
CDKN2A(A148T), and CHEK2(I157T) was found,
respectively. The NOD2(3020insC) variant allele was
found to be associated with the increased risk of BrCa
(OR=12.6; p=0.01) in this group. The mean age of can-
cer onset in mutation carriers was 3.5 years older than
in non-carriers (43.0 vs. 39.5 years). 72% of mutation
carriers originated from families with at least one cancer
in a close relative.
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These are the first study on the impact of occupational
exposure to cytostatics of persons with constitutional
mutations in cancer susceptibility genes to cancer devel-
opment. The results show an association between daily
exposure to cytostatics and the increased risk of occur-
rence of cancer in genetically predisposed healthcare
personnel of the oncohematology ward. However, we
suspect that the hereditary mutation may cause delay of
cancer onset in these persons. To confirm our supposi-
tion, it is necessary to examine a larger group of health-
care workers of oncology wards.
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